Effect of norgestrel in combination with ethinyl oestradiol on the human pituitary-adrenal axis.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000284:Administration, Oral; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000494:pharmacology; D003276:Contraceptives, Oral / Q000494:pharmacology; D003907:Dexamethasone / Q000008:administration & dosage / Q000494:pharmacology; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008797:Metyrapone / Q000008:administration & dosage / Q000494:pharmacology; D009644:Norgestrel / Q000008:administration & dosage / Q000494:pharmacology*; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D049590:Postpartum Period; D011247:Pregnancy; D013997:Time Factors
D015065:17-Hydroxycorticosteroids; D003276:Contraceptives, Oral; D004338:Drug Combinations; D009644:Norgestrel; D004997:Ethinyl Estradiol; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone